2023³â Á¦75Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãß°èÇмú´ëȸ(1ÀÏÂ÷) : 2023-10-21
±³À°ÀÏÀÚ : 2023-10-21
±³À°Àå¼Ò : ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï ÄÚ¿¢½º Çϸð´Ïº¼·ë ¿Ü
±³À°ÁÖÁ¦ : 2023³â Á¦75Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãß°èÇмú´ëȸ(1ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ
´ã´çÀÚ : ´ëÇÑÇǺΰúÇÐȸ
¿¬¶ôó : 02-3473-0284
À̸ÞÀÏ : kda@derma.or.kr
±³À°Á¾·ù : ÇǺΰú
Âü¼®¿¹»óÀÎ : 800¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 19 ½Ã°£ 3ºÐ
¼¼ºÎ¼ö°·á : 500,000¿ø
ºñ°í »çÀüµî·Ï : Á¤È¸¿ø 70,000¿ø, ÁØȸ¿ø 30,000¿ø /ÇöÀåµî·Ï : Á¤È¸¿ø 80,000¿ø, ÁØȸ¿ø 40,000¿ø /¸¸ 65¼¼ ÀÌ»ó ¸éÁ¦ / ºñȸ¿ø 500,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 10¿ù 21ÀÏ Harmony 1,2 14:00~14:05 Introduction Chair()
±³À°½Ã°£ 10¿ù 21ÀÏ Harmony 1,2 14:05~14:50 What makes us Koreans? Psychological characteristics of Korean people ÇãűÕ(°í·Á´ëÇб³ ½É¸®ÇкÎ)
Åä·Ð 10¿ù 21ÀÏ Harmony 1,2 14:50~15:00 Q&A ()
±âŸ 10¿ù 21ÀÏ Harmony 1,2 15:30~15:35 Introduction Chair()
±³À°½Ã°£ 10¿ù 21ÀÏ Harmony 1,2 15:35~16:20 Vitiligo treatment from the iron age to the age of biologics: New hope for an ancient disease John Harris(Department of Dermatology, UMass Chan Medical School, USA)
Åä·Ð 10¿ù 21ÀÏ Harmony 1,2 16:20~16:30 Q&A ()
±³À°½Ã°£ 10¿ù 21ÀÏ Vivace 14:00~14:17 ÃÊ·Ï Mycosis fungoides: A great imitator ¿À»óÈ£(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10¿ù 21ÀÏ Vivace 14:17~14:34 ÃÊ·Ï Mycosis fungoides in children and adolescents ÀÌÁöÇö(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 10¿ù 21ÀÏ Vivace 14:34~14:51 ÃÊ·Ï How to sequence therapies in mycosis fungoides, including maintenance therapy ÀÌ¿ìÁø(¿ï»êÀÇ´ë)
Åä·Ð 10¿ù 21ÀÏ Vivace 14:51~15:00 Q&A ()
±³À°½Ã°£ 10¿ù 21ÀÏ Vivace 15:30~15:47 ÃÊ·Ï Diet in atopic dermatitis ¿ìÀ¯¸®(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 10¿ù 21ÀÏ Vivace 15:47~16:04 ÃÊ·Ï Diet in psoriasis Á¤°æÀº(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 10¿ù 21ÀÏ Vivace 16:04~16:21 ÃÊ·Ï Diet in acne & rosacea ±èÁ¤Àº(¼øõÇâÀÇ´ë)
Åä·Ð 10¿ù 21ÀÏ Vivace 16:21~16:30 Q&A ()
±³À°½Ã°£ 10¿ù 21ÀÏ Harmony 1,2 16:30~16:42 ÃÊ·Ï The role of IL-23 in the pathogenesis of PsO & PsA ±èÁ¤Àº(ÇѾçÀÇ´ë)
±³À°½Ã°£ 10¿ù 21ÀÏ Harmony 1,2 16:42~16:54 ÃÊ·Ï Guselkumab ¹æöȯ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 10¿ù 21ÀÏ Harmony 1,2 16:54~17:06 ÃÊ·Ï Risankizumab ±èűÕ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10¿ù 21ÀÏ Harmony 1,2 17:06~17:18 ÃÊ·Ï Tildrakizumab, Mirikizumab ¹éÀ¯»ó(°í·ÁÀÇ´ë)
Åä·Ð 10¿ù 21ÀÏ Harmony 1,2 17:18~17:30 Q&A ()
±âŸ 10¿ù 21ÀÏ Harmony 3 14:00~14:05 Overview Chair()
±³À°½Ã°£ 10¿ù 21ÀÏ Harmony 3 14:05~14:20 ÃÊ·Ï What¡¯s new in the treatment of rosacea ±èÈ¿Áø(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 10¿ù 21ÀÏ Harmony 3 14:20~14:35 ÃÊ·Ï Lasers and more in the treatment of rosacea ½Å±âÇõ(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 10¿ù 21ÀÏ Harmony 3 14:35~14:50 ÃÊ·Ï Insights in the treatment of rhinophyma ¹Ú±Í¿µ(Áß¾ÓÀÇ´ë)
Åä·Ð 10¿ù 21ÀÏ Harmony 3 14:50~15:00 Q&A ()
±âŸ 10¿ù 21ÀÏ Harmony 3 15:30~15:35 Overview Chair()
±³À°½Ã°£ 10¿ù 21ÀÏ Harmony 3 15:35~15:45 ÃÊ·Ï Clinico-patholo-radiological correlation of vascular lasers °íÁÖ¿¬(ÇѾçÀÇ´ë)
±³À°½Ã°£ 10¿ù 21ÀÏ Harmony 3 15:45~15:55 ÃÊ·Ï Infantile hemangioma and nevus flammeus: From consultation to treatment ³ªÁ¤ÀÓ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10¿ù 21ÀÏ Harmony 3 15:55~16:05 ÃÊ·Ï PDL: The oldest but goodest for face redness À¯ÈÁ¤(°í·ÁÀÇ´ë)
±³À°½Ã°£ 10¿ù 21ÀÏ Harmony 3 16:05~16:15 ÃÊ·Ï Clinical versality of vascular laser: Acne, erythema, rosacea, and melasma ÃÖõÇÊ(ÇϴôÀ³¦ÇǺΰú)
Åä·Ð 10¿ù 21ÀÏ Harmony 3 16:15~16:30 Q&A ()
±³À°½Ã°£ 10¿ù 21ÀÏ Vivace 16:30~16:43 ÃÊ·Ï Solitary erythematous nodule on the abdomen in a 4-year-old boy ÇÏ´ë·æ(°æºÏÀÇ´ë)
±³À°½Ã°£ 10¿ù 21ÀÏ Vivace 16:43~16:56 ÃÊ·Ï Solitary subcutaneous nodule on the right cheek in a 59-year-old woman ÀÌ¿ìÁø(¿ï»êÀÇ´ë)
±âŸ 10¿ù 21ÀÏ Vivace 16:56~17:09 ÃÊ·Ï A case of violaceous malar rash with systemic symptoms ±è±¤È£(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 10¿ù 21ÀÏ Vivace 17:09~17:22 ÃÊ·Ï Brown-pigmented lines forming a band along the nail plate in a 66-year-old female ½ÉÁØÈ£(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 10¿ù 21ÀÏ Vivace 17:22~17:35 ÃÊ·Ï Pruritic erythematous patches on the trunk with lichenification on a 45-year-old woman ±èÁöÈñ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10¿ù 21ÀÏ Vivace 17:35~17:48 ÃÊ·Ï Diffuse dark reddish indurated patches on the face in a 78-year-old man À±¼÷Á¤(Àü³²ÀÇ´ë)
Åä·Ð 10¿ù 21ÀÏ Vivace 17:48~18:00 Q&A ()
±âŸ 10¿ù 21ÀÏ Allegro 08:30~08:45 Overview and introduction of board exam Examination Committee()
±³À°½Ã°£ 10¿ù 21ÀÏ Allegro 08:45~09:10 ÃÊ·Ï Keratinization, barrier development and skin immune system ½ÅÇöÅÂ(ÀÎÇÏÀÇ´ë)
±³À°½Ã°£ 10¿ù 21ÀÏ Allegro 09:10~09:35 ÃÊ·Ï Atopic dermatitis, contact dermatitis, seborrheic dermatitis, and other eczematous dermatitis ½Å±âÇõ(ºÎ»êÀÇ´ë)
ÈÞ½Ä 10¿ù 21ÀÏ Allegro 09:35~09:40 Break ()
±³À°½Ã°£ 10¿ù 21ÀÏ Allegro 09:40~10:00 Bacterial and fungal infection ¼Çö¹Î(ÇѾçÀÇ´ë)
±³À°½Ã°£ 10¿ù 21ÀÏ Allegro 10:00~10:20 Viral and other infection Áֹμ÷(ÇѾçÀÇ´ë)
±³À°½Ã°£ 10¿ù 21ÀÏ Allegro 10:20~10:40 Dermatopathology ±èÁöÈñ(¿¬¼¼ÀÇ´ë)
ÈÞ½Ä 10¿ù 21ÀÏ Allegro 10:40~10:45 Break ()
±³À°½Ã°£ 10¿ù 21ÀÏ Allegro 10:45~11:10 Papulosquamous disease ±èűÕ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10¿ù 21ÀÏ Allegro 11:10~11:25 ÃÊ·Ï Mucosal and adnexal disease Á¤ÀÇÇö(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 10¿ù 21ÀÏ Harmony 1,2 13:10~13:55 Food allergy in dermatology ¹Úõ¿í(ÇѸ²ÀÇ´ë)
Åä·Ð 10¿ù 21ÀÏ Harmony 1,2 13:55~14:00 Q&A ()
±³À°½Ã°£ 10¿ù 21ÀÏ Harmony 3 16:30~17:20 Vitiligo: Biomarkers, dosimetry & schedule in narrowband UVB phototherapy ±è±âÈ£(µ¿¾ÆÀÇ´ë)
Åä·Ð 10¿ù 21ÀÏ Harmony 3 17:20~17:30 Q&A ()
±³À°½Ã°£ 10¿ù 21ÀÏ Vivace 10:00~10:25 Beyond organoid Á¶ÀçÁø(¼¿ïÄ¡´ë)
±³À°½Ã°£ 10¿ù 21ÀÏ Vivace 10:25~10:50 Hair follicle stem cells and its updated research from the perspective of dermal milieu ±Ç¿À»ó(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10¿ù 21ÀÏ Vivace 10:50~11:15 Glimpses of stem cell uses in the clinical fields ÀÌ»óÀº(¿¬¼¼ÀÇ´ë)
Åä·Ð 10¿ù 21ÀÏ Vivace 11:15~11:30 Q&A ()
±âŸ 10¿ù 21ÀÏ Harmony 3 13:30~13:35 Introduction ()
±³À°½Ã°£ 10¿ù 21ÀÏ Harmony 3 13:35~13:55 Pathogenesis and treatment of chemotherapy-induced alopecia ±Ç¿À»ó(¼¿ïÀÇ´ë)
Åä·Ð 10¿ù 21ÀÏ Harmony 3 13:55~14:00 Q&A ()
±³À°½Ã°£ 10¿ù 21ÀÏ Vivace 09:00~09:12 ÃÊ·Ï Clinical effects of early rituximab treatment in pemphigus ±èÁ¾ÈÆ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10¿ù 21ÀÏ Vivace 09:12~09:24 ÃÊ·Ï Role of mechanical stress on fibroblasts À̽ÃÇü(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10¿ù 21ÀÏ Vivace 09:24~09:36 ÃÊ·Ï Detection of human papillomavirus in cutaneous squamous cell carcinoma in situ at special sites ¹éÀ¯»ó(°í·ÁÀÇ´ë)
±³À°½Ã°£ 10¿ù 21ÀÏ Vivace 09:36~09:48 ÃÊ·Ï Post-procedural risk assessment and prevention of post-inflammatory hyperpigmentation in senile lentigo ±Ç¼øÈ¿(°æÈñÀÇ´ë)
Åä·Ð 10¿ù 21ÀÏ Vivace 09:48~10:00 Q&A ()
±âŸ 10¿ù 21ÀÏ Harmony 1,2 11:30~11:33 Introduction Chair()
±³À°½Ã°£ 10¿ù 21ÀÏ Harmony 1,2 11:33~12:18 Guselkumab real world experience from PsO to PPP ±èº´¼ö(ºÎ»êÀÇ´ë)
Åä·Ð 10¿ù 21ÀÏ Harmony 1,2 12:18~12:30 Q&A ()
±âŸ 10¿ù 21ÀÏ Harmony 1,2 08:00~08:03 Introduction Chair()
±³À°½Ã°£ 10¿ù 21ÀÏ Harmony 1,2 08:03~08:48 Early detection and management of psoriatic disease including arthritis - what dermatologists can do Matthias Augustin(University Medical Center Hamburg, Germany)
Åä·Ð 10¿ù 21ÀÏ Harmony 1,2 08:48~09:00 Q&A ()
±âŸ 10¿ù 21ÀÏ Harmony 3 10:30~10:33 Introduction Chair()
±³À°½Ã°£ 10¿ù 21ÀÏ Harmony 3 10:33~11:18 Long-term efficacy and safety of dutasteride in AGA ÇãâÈÆ(¼¿ïÀÇ´ë)
Åä·Ð 10¿ù 21ÀÏ Harmony 3 11:18~11:30 Q&A ()
±³À°½Ã°£ 10¿ù 21ÀÏ Allegro 14:00~14:25 Perspectives on itch control for better outcomes in AD ¹Úâ¿í(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10¿ù 21ÀÏ Allegro 14:25~14:50 Expert insights on managing moderate-to-severe AD with abrocitinib ³ªÁ¤ÀÓ(¼¿ïÀÇ´ë)
Åä·Ð 10¿ù 21ÀÏ Allegro 14:50~15:00 Q&A ()